BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $290K of BioMarin Pharmaceutical Inc.
Sold$290,460
$96.82Price
3,000Shares
−1%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Tue, Jan 22. Filed Thu, Jan 24, 7:07 PM ET, after the close. Not investment advice.